Success

Decoding “metabolic memory” – how do glycemic control and variability affect epigenetic changes in young people with type 1 diabetes?

Type 1 diabetes (T1D) is the most common metabolic disease in childhood. It is caused by the destruction of pancreatic beta cells by one’s malfunctioning immune system. The lost beta cells are responsible for the production of insulin – an essential hormone in blood glucose levels regulation. Treatment of T1D demands life-long subcutaneous insulin supplementation […]

Screening for mobilization failure during hematopoietic stem cell transplantation through non-coding RNA profiling.

Transplantation of hematopoietic stem cells from bone marrow is a widely used method for treating various diseases, such as blood cancers, metabolic disorders, and autoimmune diseases. However, some patients are unable to undergo this procedure effectively due to problems with mobilizing an adequate number of stem cells. The study proposes to evaluate the role of […]

The role of proinsulin C-peptide and G-protein coupled receptor 146 (GPR146) – clinical observation of their signaling pathway’s impact on molecular pathways involved in diabetes-related complications.

The project aims to investigate the role of proinsulin C-peptide and G-protein coupled receptor 146 (GPR146) in type 2 diabetes mellitus (T2DM) complications. C-peptide is a short peptide that influences multiple cellular pathways, and its role in diabetes complications has become increasingly evident. The study postulates that C-peptide interacts with the GPR146 receptor, which may […]

Our new paper in Lancet Oncology!

We are pleased to inform about the success of our Ph.D. student Damian Mikulski, M.D. – the results of the ATLAS clinical trial (PMC006) in which he participated were published in the Lancet Oncology (IF 54.433) in the manuscript “Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients […]

Intrinsic tumour radiosensitivity as a marker of chemoradiotherapy-induced immunogenic effects in rectal cancer

Colorectal cancer (CRC) is the second leading cause of cancer death in the world. Standard treatment of patients with locally advanced cancer of the rectum includes chemoradiotherapy (CHRT) before surgery. In recent years, the new standard of treatment for some patients with CRC has become immunotherapy with the use of so-called immune checkpoint inhibitors (ICI) […]

Our youngest members among 100 Forbes Women

It is our pleasure to announce that Agata Kozajda and Julia Świerczyńska have been featured in the list of 100 Forbes Women for their work on red wine’s microRNAs and their effect on heart disease. The results of this project were presented on the final of the E(x)plory research competition. Congratulations! Read more here: https://www.forbes.pl/forbeswomen/lista-forbes-women-100-kobiet-2022-roku/kt7sejh

Medical University of Lodz Rector’s awards for research achievements in 2021

We are pleased to inform you that our team at the Department of Biostatistics and Translational Medicine has been awarded by the Rector of the Medical University of Lodz for research achievements in 2021. In total, we have been awarded 15 times, twice for international projects, 8 times for 1st-degree research achievements and 5 times for […]

Scroll to top